You have no items in your shopping cart.
You have no items in your shopping cart.
| Catalog Number | orb1274613 |
|---|---|
| Category | Antibodies |
| Description | Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid ScFv-Fc Antibody [4A6] |
| Target | N |
| Clonality | Recombinant |
| Isotype | Human IgG1 |
| Conjugation | Unconjugated |
| Reactivity | Virus |
| Form/Appearance | Liquid |
| Concentration | 5.0 mg/ml (+/- 10 %) |
| Buffer/Preservatives | PBS, pH 7.4 |
| Purification | ≥95 % |
| Immunogen | full length recombinant Nucleocapsid Protein |
| UniProt ID | P0DTC9 |
| Tested applications | ELISA |
| Application notes | Immunoreactivity: 80-120 % compared to the reference sample in an ELISA test. |
| Antibody Type | Primary Antibody |
| Clone Number | 4A6 |
| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
| Alternative names | SARS-CoV-2 (COVID-19) Nucleocapsid Antibody: Sever Read more... |
| Research Area | Infectious Disease & Virology |
| Note | For research use only |
| NCBI | QHD43423 |
| Expiration Date | 12 months from date of receipt. |
![Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid ScFv-Fc Antibody [4A6]](/images/pub/media/catalog/product/NewWebsite/15/orb1274613_1.jpg)
Immobilized 2019-nCoV Nucleocapsid Protein (Cat#orb1228242) at 5.0μg/ml (100μL/well) can bind Recombinant anti-2019-nCoV NP ScFv (4A6), the EC50 is less than 6.65ng/ml.
![Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid ScFv-Fc Antibody [4A6]](/images/pub/media/catalog/product/NewWebsite/15/orb1274613_2.jpg)
Stability is confirmed by binding ability with 2019-nCoV Nucleocapsid Protein (Cat#orb1228242). The result showed that product bioactivity is no significant differences among these samples.
![Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid ScFv-Fc Antibody [4A6]](/images/pub/media/catalog/product/NewWebsite/15/orb1274613_3.jpg)
Please note that pair recommendations are based on results obtained by our laboratory. Equally good results may be obtained using other pairs and therefore these recommendations are only indicative.
![Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid ScFv-Fc Antibody [4A6]](/images/pub/media/catalog/product/NewWebsite/15/orb1274613_4.jpg)
Freeze-thaw stability is tested by repeated freeze-thaw cycles. The result showed that product bioactivity is no significant differences after freeze-thawing 14 times.
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review